Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting

BACKGROUND: Despite the use of standardized anti-emetic guidelines, up to 20% of cancer patients suffer from moderate-to-severe chemotherapy-induced nausea and vomiting (cinv)—that is, grade 2 or greater according to the U.S. National Cancer Institute Common Terminology Criteria for Adverse Events,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bouganim, N., Dranitsaris, G., Hopkins, S., Vandermeer, L., Godbout, L., Dent, S., Wheatley–Price, P., Milano, C., Clemons, M.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3503672/
https://ncbi.nlm.nih.gov/pubmed/23300365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados